Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study

Journal of Oral and Maxillofacial Pathology

Volumn 16, Issue 1, 2012, Pages 10-15

  Kale, Alka D ^a   Mane, Deepa R ^a   Babji, Deepa ^a   Gupta, Kushboo ^a  

^a KLE VK INSTITUTE OF DENTAL SCIENCES   (India)

Author keywords

Cytokeratin; field cancerization; matrix metalloproteinase

Indexed keywords

EID: 84857877311     PISSN: 0973029X     EISSN: 1998393X     Source Type: Journal    
DOI: 10.4103/0973-029X.92966     Document Type: Article

References (22)

1. Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One2010;5:e11939.
2. Parkinson EK. Senescence as a modulator of oral squamous cell carcinoma development. Oral Oncol 2010;46:840-53.
3. Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, et al. Second cancers following oral and pharyngealcancers: Role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7. (Pubitemid 24040152)
4. Cianfriglia F, Di Gregorio DA, Manieri A. Multiple primary tumoursin patients with oral squamous cell carcinoma. Oral Oncol 1999;35:157-63. (Pubitemid 29113058)
5. Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primarymalignant tumors in patients with head and neck cancer: Results of a prospectivestudy and future perspectives. Laryngoscope 1998;108:250-6. (Pubitemid 28128216)
6. Slaughter DP, Southwick HW, SmejkalW. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
7. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 1996;56:2488-92. (Pubitemid 26170679)
8. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: Evidence for a common clonal origin. Cancer Res 1996;56:2484-7. (Pubitemid 26170678)
9. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Field Cancerisation of the oral cavity: Comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol 1997;33:332-7. (Pubitemid 28129234)
10. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L. Multiple oral squamous epithelial lesions: Are they genetically related? Oncogene 2001;20:2235-42. (Pubitemid 32531281)
11. Ogden GR, Lane EB, Hopwood DV, Chisholm DM. Evidence for field change in oral cancer based on Cytokeratin expression. Br J Cancer 1993;67:1324-30. (Pubitemid 23172872)
12. Bosch FX, Ouhayoun JP, Bader BL, Collin C, Grund C, Lee I, et al. Extensive changes in cytokeratins expression patterns inpathologically affected human gingiva. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;58:59-77. (Pubitemid 19265678)
13. Ranganathan K, Kavitha R, Sawant SS, Vaidya MM. Cytokeratin expression in oral submucous fibrosis-an immunohistochemical study. J Oral Pathol Med 2006;35:25-32.
14. Kuropkat C, Plehn S, Herz U, Dünne AA, Renz H, Werner JA. Tumour marker potential of serum matrix metalloproteinase in patients with head and neck cancer. Anticancer Res 2002;22:2221-8.
15. Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 2007;18:639-43.
16. Pelisser A, Ouhayoun JP, Sawaf MH, Forest N. Changes in Cytokeratin expression during the development of the human oral mucosa. J Periodontal Res 1992;27:588-98
17. Rahul U, Sawant S, Dange P, Kalraiya R, Ingle A, Vidya M. Implications of cytokeratins of CK 8/18 filament formation in stratified epithelial cells: Induction of transformed phenotype. Int J Cancer 2004;20:662-8. (Pubitemid 39062887)
18. Gilbert S, Loranger A, Daigel N, Marceau N. Simple epithelium keratins 8 and 18 provide resistance to Fas mediated apoptosis. The protection through a receptor-targeting modulation. J Cell Biol 2006;154:763-73. (Pubitemid 34292958)
19. Lu MH, Yang PC, Chang LT, Chao CF. Temporal and spatial sequence expression of cytokeratin K19 in cultured human keratinocyte. Proc Natl Sci Counc Repub China B 2000;24:169-77.
20. Lindberg K, Rheinwald JG. Suprabasal 40 Kd Keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 1989;134:89-98. (Pubitemid 19054982)
21. Crowe DL, Milo GE, Shuler CF. Keratin 19 down regulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 1999;78:1256-63. (Pubitemid 32501265)
22. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Yi, Muschel RJ. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumour progression. Am J Pathol 2000;157:1777-83.